Compare GMED & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GMED | BIRK |
|---|---|---|
| Founded | 2003 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 7.0B |
| IPO Year | 2012 | 2023 |
| Metric | GMED | BIRK |
|---|---|---|
| Price | $87.89 | $37.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 14 |
| Target Price | ★ $100.42 | $62.69 |
| AVG Volume (30 Days) | 952.8K | ★ 2.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 422.67 | N/A |
| EPS | ★ 3.92 | N/A |
| Revenue | ★ $2,938,931,000.00 | N/A |
| Revenue This Year | $10.72 | $13.71 |
| Revenue Next Year | $6.45 | $14.21 |
| P/E Ratio | $22.18 | ★ $17.48 |
| Revenue Growth | ★ 16.65 | N/A |
| 52 Week Low | $51.79 | $35.70 |
| 52 Week High | $101.40 | $57.39 |
| Indicator | GMED | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 46.65 | 42.23 |
| Support Level | $86.43 | N/A |
| Resistance Level | $93.85 | $42.19 |
| Average True Range (ATR) | 2.42 | 1.58 |
| MACD | -0.55 | -0.30 |
| Stochastic Oscillator | 25.58 | 23.01 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.